Focus:
Total pharma industry venture financing deals in June 2019 worth $1.09bn were announced globally, according to GlobalData's deals database. Embed this chartEmbed this chart into your websiteCopy and paste the code...
Europe's pharma industry saw a rise of 18.5% in deal activity during June 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart Embed...
Total pharma industry venture financing deals in May 2019 worth $1.21bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and...
Europe's pharma industry saw a drop of 18.5% in deal activity during May 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart Embed...
Total pharma industry deals for May 2019 worth $10.66bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste the...
North America's pharma industry saw a drop of 21.6% in deal activity during May 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart...
The US pharma industry saw a drop of 19.3% in overall deal activity during May 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this...
Total pharma industry deals for April 2019 worth $7.3bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste the...
Total pharma industry venture financing deals in April 2019 worth $1.05bn were announced in the US, according to GlobalData's deals database. Embed this chart Embed this chart into your website...
North America's pharma industry saw a rise of 5.9% in deal activity during April 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart...
